Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-04-14
1990-03-27
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549332, A61R 31335, C07D30308
Patent
active
049121324
ABSTRACT:
Novel physiologically active substances KS-504a, KS-504b and KS-504d having a vasodilative activity and a novel physiologically active substance KS-504e having an activity to inhibit histamine secretion are produced by culturing a microorganism of the genus Mollisia.
REFERENCES:
patent: 4692310 (1971-03-01), Kase et al.
Chemical Abstracts 106:100841e, "Manufacture of Histamine Release Inhibitor KT5556 with Nocardiopsis", Abstract of JP-61-176,513, (8/8/86).
The Journal of Antibiotics, vol. XXXV, No. 2, pp. 157-163, Studies on New Vasodilators, WS-1228 A and B; H. Tanaka et al.
The Journal of Antibiotics, vol. XXXV, No. 2, pp. 150-156, Studies on New Vasodilators, WS-1228 A and B.
Jpn J. Pharmacol, 43 Suppl. (1987), P-76, P-77 and P-78, p. 202P.
Ando Katsuhiko
Goto Joji
Hirayama Noriaki
Kase Hiroshi
Kawamoto Isao
Kyowa Hakko Kogyo Co. Ltd.
Raymond Richard L.
Russell Mark W.
LandOfFree
Novel substances KS-504a, KS-504b, KS-504d and KS-504e and proce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel substances KS-504a, KS-504b, KS-504d and KS-504e and proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel substances KS-504a, KS-504b, KS-504d and KS-504e and proce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1651445